Cough And Cold Symptoms, Some Coming From Omicron, Sound Like Seasonal Rebound To Perrigo
Consumer Health Product Firm Notes Potential Sales Impact From Russia’s Invasion Of Ukraine
Sales growth generated in October-December period and growing incidences of flu and cough/cold symptoms are harbingers for Perrigo in 2022. Sales during January and February in Russia and Ukraine tracked with $10m to $15m operating income firm anticipates there for 2022, “but it's really too early to estimate the potential full-year impact,” CEO Murray Kessler says.
